Photocure ASA (PHCUF)
OTCMKTS
· Delayed Price · Currency is USD
4.320
-0.853 (-16.49%)
At close: Mar 11, 2025
Photocure ASA Revenue
In the year 2024, Photocure ASA had annual revenue of 525.39M NOK with 4.94% growth. Photocure ASA had revenue of 141.68M in the quarter ending December 31, 2024, a decrease of -0.61%.
Revenue
525.39M NOK
Revenue Growth
+4.94%
P/S Ratio
2.99
Revenue / Employee
5.15M NOK
Employees
102
Market Cap
138.35M USD
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 525.39M | 24.73M | 4.94% |
| Dec 31, 2023 | 500.66M | 107.53M | 27.35% |
| Dec 31, 2022 | 393.13M | 32.59M | 9.04% |
| Dec 31, 2021 | 360.54M | 104.06M | 40.57% |
| Dec 31, 2020 | 256.48M | -25.07M | -8.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Photocure ASA News
- 2 months ago - Photocure ASA: Results for the fourth quarter of 2024 - PRNewsWire
- 5 months ago - Photocure ASA: Results for the third quarter of 2024 - PRNewsWire
- 9 months ago - Photocure ASA: Results for the second quarter of 2024 - PRNewsWire